Current through Register Vol. 51, No. 25, December 13, 2024
Section 10.18.02.01 - ScopeA. This chapter establishes the requirements for:(1) Physician reporting of a: (a) Case of human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS); and(b) Birth of an infant whose mother has tested positive for HIV;(2) Institution reporting of a case of HIV or AIDS;(3) Laboratory reporting of a test result for:(c) CD4+ cell count or percentage; or(d) HIV genotype sequence; and(4) Follow-up of: (a) A physician's report of HIV or AIDS;(b) A physician's report of an infant whose mother has tested positive for HIV;(c) An institution's report of HIV or AIDS; and(d) A laboratory's report of a test result for: (iii) CD4+ cell count or percentage; or(iv) HIV genotype sequence infection or CD4+ count.B. Except as noted in §C of this regulation, this chapter applies to all instances of laboratory testing of specimens from a human body for: (3) CD4+ cell count or percentage; or(4) HIV genotype sequence.C. This chapter does not apply if the specimen from a human body is: (1) Not tested for: (c) CD4+ cell count or percentage; or(d) HIV genotype sequence;(2) Tested for HIV detection solely for the purpose of determining the suitability of the source individual as a prospective donor of blood, semen, or tissue;(3) Taken from a patient at a designated anonymous HIV test site solely for the purpose of performing an anonymous HIV test;(4) Tested for HIV detection as part of research conducted by an institution within Maryland under the following conditions: (a) All personal identifiers are removed from the specimen before testing;(b) The specimen cannot be linked to the individual from whom the specimen was taken;(c) The result cannot be linked to the individual from whom the specimen was taken; and(d) The research protocol has been approved by an institutional review board;(5) Tested for HIV detection as part of research conducted under a research protocol approved by an institutional review board of an institution located outside of Maryland; (6) Taken from a patient known to reside outside of the United States; or(7) Tested for HIV detection as part of a research project that has been approved under Regulation .02 of this chapter for an exemption.Md. Code Regs. 10.18.02.01
Regulation .01 amended effective 47:10 Md. R. 515, eff. 5/18/2020